Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07110753 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Effect of a Combined Lifestyle Intervention for Patients With Cancer on Quality of Life

Study acronym: GLINK
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 5 more changesShow less
    • Enrollment target: estimated 244 to confirmed 221
    • Eligibility criteria expanded, about 6 words
    • Secondary endpoints: 18 to 19
    • Study description expanded, about 13 words
    • Site details revised
  2. Start date changed from estimate of Aug 1, 2025 to Sep 15, 2025
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A growing number of people are living with the (long-term) consequences of cancer and its treatment, which can negatively affect their quality of life. This study aims to assess the effect of a combined lifestyle intervention for patients with cancer on quality of life.
Trial Details
NCT Number NCT07110753
Lead Sponsor UMC Utrecht
Collaborators: Tilburg University, VU University of Amsterdam, Ede Christian University of Applied Sciences
Conditions
(from sponsor)		 Cancer
Related terms Neoplasms
Enrollment 221 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov